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PEMBANGUNAN DAN PENGOPTIMUNAN TINDAKBALAS RANTAIAN 
POLIMERASI (PCR) MULTIPLEKS UNTUK PENGESANAN SERENTAK 
SALMONELLA ENTERITIDIS, SALMONELLA TYPHIMURIUM, SALMONELLA 
WELTEVREDEN, SALMONELLA AGONA DAN SALMONELLA HEIDELBERG 
 
ABSTRAK 
Salmonella enterica adalah spesis pathogen bawaan makanan penting yang menyebabkan 
gastroenteritis dan jangkitan sistemik dalam manusia. Di Malaysia, kejadian Salmonellosis 
bawaan makanan yang disebabkan oleh serotip Salmonella bukan tifoid (NTS) semakin 
meningkat secara berkala, manakala kejadian yang disebabkan oleh Salmonella tifoid (TS) 
semakin menurun.  NTS telah diklasifikasikan sebagai punca utama wabak penyakit bawaan 
makanan di negara yang maju manakaladi negara yang sedang membangun, ia merupakan 
unsur ancaman kesihatan yang membimbangkan. Penserotipan adalah kaedah yang lazim 
digunakan untuk pembezaan pathogen ini dari 2,600 jenis serotip yang wujud. Walau 
bagaimanapun, kaedah ini mempunyai beberapa kelemahan seperti spesifisiti yang rendah, 
kaedah yang menyusahkan, mahal dan kadang-kala memberi keputusan yang mengelirukan. 
Sehingga kini, negara yang maju dan negara yang membangun di seluruh dunia masih tidak 
mempunyai asai untuk pengenalpastian and pembezaan secara serentak untuk lima jenis 
serotip NTS yang pra-dominan dan sering dipencilkan daripada pesakit gastroenteritis di 
hospital, iaitu S. Enteritidis, S. Typhimurium, S. Weltevreden, S. Agona dan S. Heidelberg. 
Oleh itu, kajian ini bertujuan untuk menghasilkan asai tindakbalas berantai polymerasi 
multiplek (mPCR) berasaskan amplifikasi jujukan asid nukleik yang unik untuk pengesanan 
dan pengesahan lima jenis serotip NTS ini secara serentak. Asai mPCR ini mengandungi 
lima pasangan primer spesifik untuk lima jenis serotip NTS dalam satu reaksi yang 
menyasarkan jujukan asid nukleik yang unik seperti yang ditentukan dengan perisian 
bioinformatik. Analisis penjujukan DNA menunjukkan bahawa hasil teramplifikasi PCR 
bagi setiap serotip adalah seperti yang dijangka. Asai mPCR ini juga mengandungi 2 jenis 
kawalan supaya kualiti yang bermutu tinggi dapat dicapai untuk asai diagnostik, iaitu 
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kawalan dalaman, gen invA untuk “Pan-Salmonella” dan kawalan amplifikasi, gen 16S 
rRNA untuk “Pan-bakteria”. Pengoptimunan yang melibatkan pengoptimunan kepekatan 
primer, kepekatan MgCl2, kepekatan gliserol, suhu sepuh lindap dan masa pemanjangan 
primer telah dijalankan untuk asai mPCR ini. Analisis kespesifikan untuk asai mPCR yang 
telah dioptimumkan adalah 100%. Kesemua 29 bakteria bukan sasaran yang mengandungi 
10 bakteria bukan Salmonella dan 19 spesis Salmonella bakteria telah diuji negatif manakala 
bakteria sasaran NTS diuji positif dalam sampel spika tunggul hidup. Analisis kepekaan 
untuk asai mPCR bagi kesemua 5 jenis serotip NTS adalah >1000 CFU/ml atau 10 pg/µl 
untuk DNA genom bakteria. Asai ini juga disahkan 100% sensitif kepada 116 isolat klinikal 
dari sumber tempatan dan luar negara. Kesimpulannya, satu mPCR yang sensitif, spesifik 
dan murah telah dihasilkan untuk pengesanan secara serentak bagi 5 jenis serotip NTS yang 
pradominan dan sering dipencilkan di serata dunia. Teknik ini boleh digunakan secara 
langsung dan mudah untuk ditubuhkan dalam makmal rutin yang lengkap dengan 
penyediaan DNA dan kemudahan asai PCR. Asai ini adalah satu penemuan yang unggul 
untuk diagnosis makmal bagi Salmonella bukan tifoid dan ia juga boleh digunakan untuk 




DEVELOPMENT AND OPTIMIZATION OF A MULTIPLEX PCR ASSAY FOR 
SIMULTANEOUS IDENTIFICATION OF SALMONELLA ENTERITIDIS, 
SALMONELLA TYPHIMURIUM, SALMONELLA WELTEVREDEN, 
SALMONELLA AGONA, AND SALMONELLA HEIDELBERG 
 
ABSTRACT  
Salmonella enterica are a species of important food-borne pathogens that cause 
gastroenteritis and systemic infections in humans. The incidence of food-borne 
Salmonellosis due to non-typhoidal Salmonellae (NTS) serotypes is increasing periodically 
while typhoidal Salmonellosis (TS) decreases in Malaysia. NTS have been classified as the 
leading cause of food-borne disease outbreaks in developed countries and are also a public 
health concern in developing countries. Serotyping is the conventional method used for 
differentiating these pathogens from the 2,600 serotypes known to exist. However, this 
method has a number of disadvantages including low specificity, costly, laborious and 
sometimes the results are ambiguous. Until today, there is still no assay available for 
simultaneous identification and differentiation of the five  predominant NTS serotypes, i.e., S. 
Enteritidis, S. Typhimurium, S. Weltevreden, S. Agona, and S. Heidelberg, which are 
increasingly being isolated in hospitalized-gastroenteritis patients in both developed and 
developing countries worldwide. Thus, the aim of this study was to develop a multiplex PCR 
(mPCR) assay to enable the simultaneous detection and confirmation of these five NTS 
serotypes based on amplification of their unique nucleic acid sequences. The mPCR assay 
consists of 5 pairs of specific primers in a single reaction that target the unique nucleic acid 
sequences of the 5 NTS serotypes, which were determined by using bioinformatic tools. 
Sequencing data showed that the amplified PCR products of the serotypes were as expected 
of their target genes. The mPCR assay also contained two controls, i.e., an internal control 
(IC) Pan-Salmonella gene (invA) and an amplification control (AC) Pan-bacteria gene (16s 
rRNA), to ensure high quality required for diagnostic assays. Optimization of the mPCR 
assay was carried out by adjusting primers’ concentrations, MgCl2 concentrations, glycerol 
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concentrations, annealing temperatures and primers’ extension times. The analytical 
specificity of the optimized mPCR assay was 100%; all 29 non-target bacteria consisting of 
10 non-Salmonella bacteria and 19 other known Salmonella species tested negative while all 
5 reference NTS bacteria tested positive in spiked stool samples. The analytical sensitivity of 
the mPCR assay for all 5 NTS serotypes was <1000 CFU/ml or <10 pg/µl of bacteria 
genomic DNA.The assay was also validated using 116 clinical isolates from local and 
foreign sources which show 100% sensitivity. In conclusion, a sensitive, specific and cost-
effective mPCR has been developed for simultaneous detection of the 5 predominant NTS 
serotpes isolated worldwide. The technique employed is straightforward and easily 
established in standard laboratories equipped with DNA preparation and PCR facilities. This 
assay is a breakthrough for laboratory diagnosis of non-typhoidal Salmonellosis, and is 










1.1 Non-Typhoidal Salmonellae 
Non-typhoidal Salmonellae (NTS) are the main causes of bacterial food-borne disease 
outbreaks in developing countries and are also a public health concern in developed 
countries (Andrysiak et al., 2008; Learn-Han et al., 2008). NTS infections are not only 
restricted to humans but they are capable of infecting a broad range of animals, including 
mammals, reptiles, birds and insects (Hohmann, 2001). However, there are some NTS that 
have restricted ability to infect only one type of animal. For example Salmonella 
Arbortusovis is restricted to sheep and Salmonella Gallinarium to poultry (Bhowmick et al., 
2011). Generally, Salmonellae are facultative anaerobic, gram-negative, rod-shaped bacilli 
and belong to the family of Enterobacteriaceae (Lim & Thong, 2009). The size of 
Salmonellae are approximately 0.7 to 1.5 µm wide and 2.0 to 5.0 µm in length (Giannella, 
1996).  NTS usually ferment glucose with production of gas and they are grouped as 
prototrophic because of their ability to grow in a minimal amount of medium containing 
glucose as a source of carbon and ammonia as a source of nitrogen. They can be 
phenotypically identified by urea hydrolysis, absence of tryptophan deaminase, non-lactose 
fermentation, production of hydrogen sulphide (H2S) gas, and growth in Simmons citrate 
agar (Grimont et al., 2000). 
 
1.1.1 Nomenclature of Salmonellae 
The genus Salmonella has a confusing background in aspect of classification and 
nomenclature because scientists use different systems to refer to and communicate about this 
genus. There are more than 2,600 serotypes and the number is still growing with newly 
identified serotypes every year (Bopp et al., 2003; Brenner et al., 2000). Salmonella was 
discovered in the year 1886 by Theobald Smith, who worked on swine fever (hog cholera) 
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and later he named the genus after his supervisor, Daniel Elmer Salmon (Grimont et al., 
2000). Classification of Salmonella started when Bruce White developed a method for 
analysis of somatic and flagella antigens of the bacteria in 1926. Later in 1961, Fritz 
Kauffmann expanded the method to identify more than 2,000 serotypes. In 1980, the 
Kauffmann-White scheme was proposed as a systematic Salmonella nomenclature, and is 
currently maintained by The World Health Organization (WHO) (Brenner et al., 2000; 
Grimont et al., 2000; Hohmann, 2001).  
 
Currently, molecular methods have shown that the genus Salmonellae consist of only two 
species, Salmonella enterica and Salmonella bongori (Le Minor & Popoff, 1987; Reeves et 
al., 1989; Threlfall & Frost, 1990). The species Salmonella enterica is further divided into 
six subspecies as follows: (1) Salmonella enterica subspecies enterica, (2) Salmonella 
enterica subspecies salamae, (3) Salmonella enterica subspecies arizonae, (4) Salmonella 
enterica subspecies diarizonae, (5) Salmonella enterica subspecies houtenae, and (6) 
Salmonella enterica subspecies indica. Salmonella enterica subspecies enterica is the most 
common clinically identified pathogen and is usually named after the geographical location 
in which there were first discovered in order to avoid confusion (Table 1.1) (Grimont et al., 
2000; Su & Chiu, 2007).  
 
1.1.2 Laboratory Identification of Non-Typhoidal Salmonellae 
Traditionally, phenotypic identification methods like bacteriophage typing or phage typing, 
biotyping, colicin typing, resistance typing and serotyping have been employed for 
Salmonellae identification during an outbreak investigation (Threlfall & Frost, 1990). 
Currently, the conventional bacteria culture method, such as low-selective media 
(MacConkey agar) or intermediate-selective media (Shigella-Salmonella xylose-lysine 
deoxycholate, XLD agar), is widely used. Although this method requires less skill, it is time 
consuming. All NTS will grow as red colonies with black centers on XLD medium. 
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Salmonella bacteria are further tested on a panel of biochemical tests in order to identify the 
species (Table 1.2) (ISO-6579-4, 2002; Mikoleit, 2009).  
 
Another method for Salmonella enterica identification is using conventional serotyping 
method. This method utilizes specific antisera, which are IgM and IgG antibodies against the 
somatic (O) and flagella (H) antigens, respectively, in order to determine the serotype (Table 
1.3) (Grimont & Weill, 2007; Guibourdenche et al., 2010; Hiriart et al., 2013; Pokhrel et al., 
2009). Although this method is considered as the gold standard of Salmonella identification 
and differentiation, it has poor discriminatory power, costly and limited in the availability of 
the antisera (Cardona-Castro et al., 2009; Zou et al., 2010). Such limitations have 
encouraged the development of molecular “serotyping” methods based on  amplification of 
specific DNA sequences for identification of Salmonella serotypes (Cardona-Castro et al., 
2009; Herrera-Leon, 2004; Lim & Thong, 2009; Nori, 2010; Zou et al., 2010).  
 
1.2 Salmonellosis 
Salmonellosis or commonly known as gastroenteritis is an infection caused by non-typhoidal 
Salmonellae (NTS) which is clinically indistinguishable from that due to many other enteric 
bacteria (Hohmann, 2001). More than 95% of the transmission of Salmonellae are via the 
oral-fecal route commonly caused by consumption of contaminated food and water 
(Biologics, 2005). Salmonellae infections have a short episode of disease lasting less than 10 
days, which consists of an incubation period of 12 to 72 hours post-infections, and then 
symptoms such as nausea, vomiting and self-limited diarrhea. Sometimes, asymptomatic 





Table 1.1: Nomenclature of Salmonellae (Adapted from Su & Chiu, 2007) 












(Capitalized, not italic)* 






  salamae (subspecies II) 9, 46:z:z39 505 
  arizonae (subspecies IIIa) 43:z29:- 99 
  
diarizonae (subspecies 
IIIb) 6,7:1, v:1,5,7 336 
  houtenae (subspecies IV) 21 :m, t:- 73 
  indica (subspecies VI) 59:z36:- 13 
 bongori subspecies V 13,22:z39:- 22 
Total 2579 
*some selected serotypes (serovars) are listed as examples 
 
 
Table 1.2: Biochemical Tests for Identification of NTS (Adapted from ISO 6579) 
Organism 
Triple Sugar Iron Test Motility, Indole, Urea Tests Citrate 
Test Slant Butt H2S Gas Motility Indole Urea 
Non-Typhoidal 
Salmonella spp. Alkaline Acid V V + - - V 
E. coli Alkaline Acid - + + + - - 
Klebsiella spp. Acid Acid - + - V + + 
Citrobacter spp. V Acid + + + V - + 
Proteus spp. Alkaline Acid + + +  + V 
 
‘+’ = Positive 
‘-’ = Negative  
Wk+ = Weak positive 
V = Variable result 







Table 1.3: Serological Identification of NTS (Adapted from Grimont, 2007) 
Serotype O antigen H1 antigen H2 antigen Serogroup Phase 1:2 
S. Enteritidis 1, 9, 12 g,m - Group D1 
S. Typhimurium 1, 4, (5), 12 i 1,2 Group B 
S. Weltevreden 3, (10), (15) r z6 Group E 
S. Agona 1, 4, (5), 12 f,g,s (1,2) Group B 







1.2.1 Manifestation of Non-Typhoidal Salmonellosis 
Non-typhoidal Salmonellae (NTS) infections in most cases result in self-limited 
gastroenteritis. During the course of infection, Salmonella colonizes the intestines and 
messentric lymph nodes (Raffatellu et al., 2006; Zhang et al., 2002). The symptoms, such as 
nausea, vomiting and diarrhea are frequently reported in the event of gastrointestinal 
manifestation. At this stage, stools are loose and in moderate volume, without the presence 
of blood. (Manatsathit et al., 2002; Saphra & Winter, 1957). In most cases, fever usually 
resolve within 48 to 72 hours post-infection, whereas diarrhea typically lasts from 3 to 7 
days (Coburn et al., 2007; Saphra & Winter, 1957). Sometimes, patients require 
hospitalization for dehydration treatment and deaths are not common. However, deaths do 
occur among elderly and immunocompetent patients (Buchwald & Blaser, 1984). The 
infected but recovered individuals may continue to secrete stools containing NTS after 
resolution of the infection for 4 to 5 weeks depending on the Salmonella serotype (Celum et 
al., 1987).  It is uncommon for patients with gastrointestinal infection caused by NTS to 
develop bacteremia. However, there are approximately 5% of infected individuals who 
develop bacteremia, which is a serious and fatal problem (Celum et al., 1987; Han et al., 
1967; Hohmann, 2001).  
 
1.2.2 Chronic Carrier Stage and Localized Infections 
The frequency of NTS to persist in the stool and urine after 1 year course of infection is 
relatively low, from 0.2 to 0.6% (Cruickshank & Humphrey, 1987; Musher & Rubenstein, 
1973). It is more common to have other complications like focal infections. Focal infections 
occur when the Salmonella causes localized infections in other organs rather than in the gut 
(Lee et al., 2005). The phenomena of extraintestinal infections have been classified into four 
groups; (1) primary bacteremia, (2) secondary bacteremia, (3) digestive focal infections, and; 
(4) non-digestive focal infections (Ramos et al., 1996). Between 8 to 17% of patients 
affected with NTS bacteremia develop focal complications (Galofré et al., 1994; Grisaru-
Soen et al., 2004; Zaidi et al., 1999). Commonly, urinary isolates of Salmonella may 
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erroneously be attributed to fecal contamination or urinary tract colonization (Abbott et al., 
1999). There are other complications contributed by focal infections, such as osteomyelitis 
and joint infections (Workman et al., 1996), severe and prolonged polyarticular reactive joint 
disease (Mattila et al., 1994; Mattila et al., 1998), and central nervous system (CNS) 
infections (Kinsella et al., 1987).  
 
1.2.3 Epidemiology of Non-Typhoidal Salmonellosis 
Non-typhoidal Salmonellae (NTS) are commonly isolated bacterial pathogens in the 
laboratory upon the diagnosis of diarrhea (Hohmann, 2001). These microorganisms can 
reside in the gastrointestinal tracts of animals and humans and cause various stages of 
gastrointestinal disease (Winokur, 2003). The World Health Organization (WHO) has 
estimated that NTS cause 1.3 billion cases of gastroenteritis or diarrhea, with 3 million 
deaths annually (Nair et al., 2002). The global NTS infections surveillance data suggests that 
the incidence of non-typhoidal Salmonellosis has increased during the last couple of decades  
(Molbak, 2006). Several countries including Malaysia have experienced decrease in the 
incidence of Salmonella Typhi while NTS serotypes have lately increased proportionally and 
in absolute numbers (Yasin et al., 1995).  
 
In Malaysia, non-typhoidal Salmonellosis is endemic, and its incidence appears to be 
increasing with periodic outbreaks (Thong et al., 1994). Similar situation is observed in the 
state of Kelantan, where large numbers of NTS isolated from Hospital Universiti Sains 
Malaysia (HUSM) usually occur during the fasting month of Ramadhan (unpublished data). 
In particular, onset of the outbreak during the festive season is due to lack of hygienic 
practices among food-handlers throughout the food-handling process. Commonly, NTS are 





Amongst the NTS serotypes, S. Typhimurium and S.Enteritidis are the two predominant 
agents associated with food-borne non-typhoidal Salmonellosis (Jegathesan, 1984; Nori, 
2010; Yasin et al., 1995). S. Weltevreden is the third most common serotype isolated with 
hospitalized-gastroenteritis in developing countries, such as countries in Southeast Asia and 
India (Bangtrakulnonth et al., 2004; Boonmar et al., 1998; Jegathesan, 1984; Sood & Basu, 
1979; Yasin et al., 1995). This serotype also caused a few major food-borne outbreaks in 
Malaysia as well as in developed countries, such as Europe and the United States (Aarestrup 
et al., 2003; D'Ortenzio et al., 2008; Emberland et al., 2007; Learn-Han et al., 2008; Ponce 
et al., 2008). S. Agona and S. Heidelberg are not the most commonly isolated serotypes in 
Malaysia. However, they are amongst the most predominant serotypes causing human illness 
in developed countries (Andrysiak et al., 2008; Boyd et al., 2002; Bronowski & Winstanley, 
2009) 
 
1.3 Multiplex Polymerase Chain Reaction 
Multiplex Polymerase Chain Reaction (mPCR) is a subset of the Polymerase Chain Reaction 
(PCR). It is defined as simultaneous amplification of multiple sequences of target DNA in a 
single reaction. It is a technique developed to save time and effort (Markoulatos et al., 2002). 
This technique requires a combination of several primer pairs with single or multiple DNA 
template(s) in a single reaction (Edwards & Gibbs, 1994). The availability of the genetic 
information of the target DNA is important to ensure that the mPCR works. This technique 
has been broadly used as screening tests for microbial agents due to its versatility in 
simultaneously detecting multiple agents that cause similar or identical clinical syndromes, 
as well as those that might share similar epidemiological features (Lim, 2009). Hence, this 
technique is widely used in research laboratories (Markoulatos et al., 2002).   
 
Although PCR is a powerful tool for amplification of nucleic acid sequences, it requires a 
thorough optimization in order to successfully yield an amplification of a particular DNA 
segment. The use of the same protocol on another gene segment may require minor 
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optimization on the PCR components and thermal cycling parameters (Stephenson, 2012). 
Since the development of an efficient mPCR assay is a greater challenge than a monoplex 
PCR assay, strategic planning is required to optimize the reaction conditions (Lim, 2009). 
The challenge of mPCR is designing the primer sets which have compatible annealing 
conditions (Schoske et al., 2003).  
 
Ideally, there are a few parameters that need to be taken into account for primer selection 
such as; (1) primers length from 18 to 24 bp is long enough to confer high specificity of 
complementary to the desired nucleic acid sequences (Baumforth et al., 1999; Wu et al., 
1991); (2) GC content of the primers must be within 50 to 60% to avoid formation of 
secondary structures (Kramer & Coen, 2001; Wu et al., 1991); (3) all the primers must have 
similar melting temperatures (60 ± 1oC), and; (4) the primers’ sequences homology towards 
the target nucleic acid sequences (Henegariu et al., 1997; Nicodème & Steyaert, 1997; 
Robertson & Walsh-Weller, 1998). Also, primers should not exhibit significant homology to 
each other in order to avoid primer-dimer formation, which is a common artifact that has 
been observed when the primers themselves become the template and are taken through 
many amplification cycles (Cha & Thilly, 1993; Kramer & Coen, 2001). This mispriming 
may be due to high primer concentration coupled with low template concentration at the 
beginning of the amplification reaction.  
 
The relative concentrations of the primers must be adjusted and optimized to achieve the 
same or similar amplification efficiencies for each DNA target in a single tube of reaction 
(Schoske et al., 2003). Ideally, the primers’ concentrations should be ascertained using a 
titration method and should not be greater than 1.0 µM because high primers’ concentrations 
will promote mispriming as described above (Baumforth et al., 1999; Brownie et al., 1997; 




Magnesium chloride (MgCl2) is one of the most critical components in any PCR assay 
because its concentration can affect the specificity and efficiency of the reaction (Raj, 2014). 
This compound is a salt which can dissociate into two ions, Mg2+ and Cl-. The Mg2+ is 
divalent and it can affect the PCR differently at high and low concentrations. The primary 
function of Mg2+ is to destabilize the double helix structure of DNA, in order to allow the 
primer to anneal with the complementary target site, at the same time, enable the polymerase 
enzyme to unwound the DNA template. Excess Mg2+, however, stabilizes the double-
stranded DNA structure and prevent complete denaturation of the target during 
thermocycling process, resulting in a reduction of the PCR yield (Kidd, 1995). This could 
also be due to spurious annealing of primers to incorrect template sites, therefore resulted in 
larger amounts of undesired PCR products. On the other hand, insufficient Mg2+ 
concentration  impair the primer extension process as Mg2+ is the co-factor for the enzymatic 
activity for most DNA polymerases (Baumforth et al., 1999).  
 
Optimization of the mPCR cycling parameters such as annealing temperatures is also 
critically to ensure that one reaction is not dominant over the other (Henegariu et al., 1997). 
The annealing temperature chosen for a PCR usually depends on the duration of exposure to 
the target and composition of the primers. The ideal annealing temperature of a primer 
should be 5oC below its melting temperature, as it can affect the PCR differently at high or 
low temperatures (Kidd, 1995). Too low annealing temperatures will result in non-specific 
binding of primers to DNA sequences other than the true target; thereby reducing the yield of 
the desired product and specificity of the test. Conversely, too high annealing temperatures 
may yield little product as primer annealing is reduced (Stephenson, 2012). The suggested 
annealing time is 30 seconds for small volume (20 µl) PCR as the temperature equilibrate 
quickly (Kidd, 1995).  
 
The utilization of PCR adjuvants, such as dimethyl sulfoxide (DMSO), glycerol and bovine 
serum albumin (BSA) have been shown to improve PCR amplification efficiency and 
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specificity, and at the same time, overcome difficulties encountered with high GC content or 
long DNA templates (Hengen, 1997; Kramer & Coen, 2001; McElhinney, 1995). The 
optimum concentration of PCR adjuvants, particularly glycerol need to be optimized in order 
to favor mPCR assays (Henegariu et al., 1997). Glycerol is used to enhance the efficiency 
and specificity of DNA polymerases and primers by preventing the formation of secondary 
structures caused by GC-rich regions during DNA amplification, and improve the 
association between enzyme and template by lowering the strand separation temperatures of 
DNA thereby facilitating DNA amplification (Lee, 1997; Rees et al., 1993; Saikar et al., 
2013). 
 
1.4 Significance of Study 
Human Salmonellosis outbreaks and occurrences are highly related to the environment. Its 
increasing prevalence and high frequency in the global food chain and its virulence and 
adaptability has impacted the medical, public health and economy of many countries 
worldwide (Dunbar et al., 2003; Freitas Neto et al., 2010; Hornick, 1994). Globally, the 
incidences of Salmonella infections have increased markedly as good surveillance systems 
are lacking in many countries, including Malaysia. Although there are many established 
methods for detection and characterization of NTS, which includes a series of 
microbiological and biochemical tests (Dunbar et al., 2003) followed by antisera serotyping 
(Hohmann, 2001; Nori, 2010; Threlfall & Frost, 1990), the whole process is laborious, time 
consuming, require skilled personnel, and the results obtained can be confusing due to the 
large numbers of antisera needed, as well as the cross-reactivity between certain serotypes or 
with other enteric bacteria (Bäumler et al., 2000; Luderitz et al., 1966; Ng et al., 1976).  
 
There has been many studies done in the past decades to differentiate Salmonella serotypes 
by using whole genome sequencing, comparative genomic techniques, molecular typing and 
Salmonella DNA fingerprinting. These studies have shown that bacteria in the genus 
Salmonella have about 90% similarities in their genome (Crosa et al., 1973; Kang et al., 
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2006; Leekitcharoenphon et al., 2012). The remaining 10 to 12% of their chromosome DNA 
were shown to be unique for each serotype. These unique gene fragments are hypothesized 
to be due to horizontal gene transfer (Bäumler, 1997),  lateral gene transfer (Ochman et al., 
2000), and gene rearrangement processes such as insertions, deletions, inversions, and 
translocations within its genome relative to each serotypes (Doublet et al., 2008). The unique 
regions are distributed in many sites on the chromosomes and they are likely to encode gene 
products which account for the different abilities of the serotypes, such as pathogenesis 
(Kang et al., 2006; Leekitcharoenphon et al., 2012; Ochman et al., 2000).  
 
The mPCR is a powerful technique because it has the ability to detect minute quantities of 
DNA through amplification of a particular DNA segment, as well as its ability to 
discriminate between different organisms in one reaction even though they are closely 
related. This rapid, robust and cost effective technique has been widely employed in the 
detection, identification, and differentiation of Salmonella serotypes (Edwards et al., 2002; 
Greisen et al., 1994; Jitrapakdee et al., 1995; Tennant et al., 2010). In a recent study, a 2-
sequential mPCR assay was developed to serotype somatic (O), capsular (Vi) and flagellar 
(H) genes present on Salmonella bacteria (Lim, 2009; Lim & Thong, 2009). Although this 
approach was aimed at Salmonella grouping and differentiation based on their genetic 
information, it has a number of drawbacks such as, the method is laborious, time consuming 
and the mPCR showed low specificity and sensitivity.  
 
Therefore, this study was focused on the development and optimization of a mPCR assay 
based on single specific-gene detection for each serotypes. Currently, there is no single assay 
that allows simultaneous detection and identification on the five most commonly isolated 
NTS serotypes, i.e., Salmonella Enteritidis, Salmonella Typhimurium, Salmonella 
Weltevreden, Salmonella Agona, and Salmonella Heidelberg based on their genomes. Since 
the identification of Salmonella serotypes using conventional methods is tedious, expensive 
and time consuming, this study was aimed at developing an alternative method using multi-
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target genes amplification mPCR which enabled rapid and specific detection of the five NTS 
serotypes causing disease in humans. In addition, to providing a better diagnostic tool for 
early detection of Salmonella infections this mPCR assay can improve the Salmonella 
surveillance system in Malaysia.  
 
1.5 Objectives of Study 
The main objective of this research was to develop an optimized multiplex PCR (mPCR) 
assay using specific gene targets to simultaneously identify S. Enteritidis, S. Typhimurium, S. 
Weltevreden, S. Agona, and S. Heidelberg in clinical isolates. The sub-objectives of this 
study were:- 
 
1. To identify unique DNA sequences of S. Weltevreden, S. Agona, and S. Heidelberg 
using bioinformatic approaches to elucidate specific gene targets for identification of 
these pathogens, 
 
2. To develop and optimize five monoplex PCR assays using the gene targets delineated 
above, 
 
3. To develop and optimize a mPCR assay from the above monoplex PCR assays for 
simultaneous detection of S. Enteritidis, S. Typhimurium, S. Weltevreden, S. Agona and 
S. Heidelberg, and 
 
4. To determine the analytical sensitivities and specificities of the mPCR assay using 





MATERIALS AND METHODS 
 
2.1  Materials 
2.1.1 Chemicals, Media and Reagents 
All chemicals, media and reagents listed in Table 2.1 were used for isolation and 
identification of Salmonella in clinical samples. These chemicals and media were imported 
either directly from the manufacturers or procured through their Malaysian agents.   
 
Table 2.1: List of Chemicals, Media and Reagents 
No. Name Source 
1. Absolute Ethanol HmbG chemical, Germany 
2. Glacial Acetic acid, 100% Merck, Germany 
3. Agarose powder, analytical grade Promega, USA 
4. Dimethyl sulfoxide (DMSO) New England Biolabs, USA 
5. Ethidium bromide (10 mg/ml) Promega, USA 
6. Ethylenediamine tetracetic acid (EDTA) Fluka Analytical, USA 
7. Glycerol Merck, Germany 
8. Indole reagent (KOVACS) Remel, UK 
9. Methyl red solution Remel, UK 
10. Methyl red Vogas-Proskauer (MRVP) medium Oxoid Ltd, UK 
11. Nutrient agar powder Oxoid Ltd, UK 
12. Nutrient broth powder Oxoid Ltd, UK 
13. Polyvinylpyrrolidone (PVP) Calbiochem,  
14. Selenite cystine broth Fluka Analytical, USA 
15. Simmons citrate agar Oxoid Ltd, UK 
16. Sodium chloride (NaCl) Merck, Germany 
17. Sulfide indole motility (SIM) medium Oxoid Ltd, UK 
18. Triple sugar iron (TSI) medium Oxoid Ltd, UK 
19. Tris (hydroxymethyl) aminomethane Bio-Rad, USA 
20. Urea Amresco, USA 
21. Urea agar base Oxoid Ltd, UK 





2.1.2 Research Kits and Consumables 
All research kits listed in Table 2.2 were used for extraction of Salmonella DNA from 
clinical samples. QIAGEN brand research kits were mainly used in this study.  
 
All laboratory comsumables listed in Table 2.2 were regularly used and replacements were 
required throughout the research work. These laboratory comsumables were procured 
through their Malaysian agents.  Greiner Bio-One (Germany) and Axygen (USA) were 
mainly used. 
 
Table 2.2: List of Research Kits and Consumables 
No. Name Source 
1. Cryotube with screw cap 2.0 ml Axygen, USA 
2. DNEasy Blood & Tissue Kit (250) QIAGEN, Germany 
3. Micro-centrifuge tubes 1.5 ml, 0.2 ml Axygen, USA 
4. Pipette tips 5.0 ml, 1.0 ml, 200 µl, 10 µl Axygen, USA 
5. Petri dish Greiner Bio-One, Germany 
6. Polypropylene tubes 15 ml, 50 ml Greiner Bio-One, Germany 




All software listed in Table 2.3 were used in the analysis and interpretation of results 
obtained in this study.  
 
Table 2.3: List of Software 
No. Name Purpose Source 
1. SynGene Genesnap Version 7.09 Gel documentation SynGene, UK 
2. ND-1000 Version 3.5.2 DNA quantification ThermoScientific, USA 






All the instruments listed in Table 2.4were used for bacterial storage, culture and other 
molecular biology experiements in this study.  
 
Table 2.4: List of Instruments 
No. Name Source 
1. Analytical balance A&D Company Ltd, Japan 
2. Autoclave machine Hirayama, Japan 
3. Chiller (4oC) Hitachi, Japan 
4. Deep Freezer (-80oC) ThermoScientific, USA 
5. Dry Bath incubator Labnet, USA 
6. Dry Oven Memmert, Germany 
7. Freezer (-20oC) ThermoFisher, USA 
8. Gel electrophoresis Sub-Cell GT Bio-Rad, USA 
9. Gel eletctrophoresis MiniSub-Cell GT Bio-Rad, USA 
10. Gel documentation chamber SynGene, UK 
11. Incubator Memmert, Germany 
12. Incubator shaker ThermoScientific, USA 
13. ND-1000 Spectrophotometer ThermoScientific, USA 
14. PCR thermal cycler MJ Research, Canada 
15. pH meter Villerbanne Cedey, France 
16. Power pack Bio-Rad, USA 
17. Steamer KSI KOSH, Germany 
18. Table top centrifuge (1.5 ml) FisherScientific, USA 
19. Table top centrifuge (0.2 ml) Tomy Digital Biology, Japan 
20. Vortex Sigma-Aldrich, USA 
 
2.1.5 PCR Reagents 
All Taq polymerase and dNTPs were used in the monoplex PCR and Multiplex PCR assays 
whilst DNA molecular weight marker was used as reference standard to determine the size 
of PCR amplicons were listed in Table 2.5. All the enzymes, DNTPs and molecular weight 
marker were stored ar -20oC freezer (Thermo Fisher, USA).  
 
Table 2.5: List of PCR Reagents 
No. Name  Source 
1. GoTaq® Flexi DNA Polymerase (500 U) Promega, USA 
2. Phusion® High-Fidelity DNA Polymerase New England Biolabs, USA 
3. DNA Ladder (100 bp) Promega, USA 
4. Deoxyribonucleotide triphosphate (dNTP) mix Promega, USA 
5. Green GoTaq® Flexi Buffer (5X) Promega, USA 
6. Magnesium chloride solution, 25 mM Promega, USA 
7. Phusion® High Fidelity Buffer New England Biolabs, USA  
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2.1.6 Bacteria Isolates 
Thirty-nine isolates were obtained from three different sources, i.e., Biobank, Institute for 
Research in Molecular Medicine (INFORMM), Hospital Universiti Sains Malaysia (HUSM) 
and American Type Cell Culture (ATCC) which consisted of 29 known Salmonella spp. and 
10 non-Salmonella bacteria used for analytical specificity of the monoplex and multiplex 
PCR assays as tabulated in Table 2.6. 
 
A total of 116 Salmonella isolates were obtained from four different sources, i.e., the 
Department of Clinical Microbiology and Parasitology, Hospital Universiti Sains Malaysia 
(HUSM), Denmark Technology University (DTU), University of Liverpool, and University 
of California, Irvine (UCI) were used for analytical sensitivity of the monoplex PCR assays 
as tabulated in Table 2.7.  
 
Table 2.6: Salmonellaand Non-Salmonella Strains used in Analytical Specificity Tests 
No.  Strain Strain ID No. Source 
1.  Salmonella Typhi 7251 ATCC 
2.  Salmonella Paratyphi A 9150 ATCC 
3. Salmonella Paratyphi B BAA 1250 ATCC 
4. Salmonella Paratyphi C 9068 ATCC 
5. Salmonella Enteritidis 13076 ATCC 
6.  Salmonella Typhimurium 14028 ATCC 
7. Salmonella Poona 04840 ATCC 
8.  Salmonella Hadar 51956 ATCC 
9.  Salmonella Weltevreden 6534 ATCC 
10. Salmonella Agona 51957 ATCC 
11. Salmonella Heidelberg 8326 ATCC 
12.  Salmonella Braenderup MOB316/06 INFORMM Biobank 
13.  Salmonella Regent MOB491/06 INFORMM Biobank 
14. Salmonella Kibi 3124K/07 INFORMM Biobank 
15.  Salmonella Tsevie D1746K/07 INFORMM Biobank 
16.  Salmonella Farsta D1361K/07 INFORMM Biobank 
17. Salmonella Uppsala D1354/07 INFORMM Biobank 
18.  Salmonella Brooklyn D1726K/07 INFORMM Biobank 
19.  Salmonella Assinie D1767/07 INFORMM Biobank 
20. Salmonella Richmond D1832K/07 INFORMM Biobank 
21.  Salmonella Bardo D1874K/07 INFORMM Biobank 
22.  Salmonella Tshiongwe MOB1228/06 INFORMM Biobank 
23. Salmonella Emek 3264/07 INFORMM Biobank 
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25.  Salmonella Mbandaka B08680/10 HUSM  
26. Salmonella Javiana S00617/10 HUSM  
27. Salmonella Albany S00306/11 HUSM  
28. Salmonella Standley S00353/11 HUSM  
29. Salmonella Oslo S00751/10 HUSM  
30. Salmonella Newport B08147/10 HUSM  
31. Escherichia coli ESCO ATCC 
32. Shigella dysentriae SHDY/150/09 INFORMM Biobank 
33. Shigella boydii SHBO/150/199/A INFORMM Biobank 
34. Shigella flexneri S00001/11 HUSM  
35. Shigella sonnei S00014/11 HUSM  
36. Enteropathogenic Escherichia coli S00024/11 HUSM  
37. Enterohemorrhagic Escherichia coli S00022/11 HUSM  
38. Yersinia enterocolitica B06102/08 HUSM  
39. Klebsiella pneumonia B02148/09 HUSM  
 
Table 2.7: Salmonella Clinical Isolates used in Sensitivity Tests 
No.  Strain Strain ID No. Year Source 
1.  Salmonella Enteritidis B04106/10 2010 HUSM  
2.  Salmonella Enteritidis B05708/10 2010 HUSM  
3. Salmonella Enteritidis B08268/10 2010 HUSM  
4. Salmonella Enteritidis B08347/10 2010 HUSM  
5. Salmonella Enteritidis B08572/10 2010 HUSM  
6.  Salmonella Enteritidis B10162/10 2010 HUSM  
7. Salmonella Enteritidis S00194/10 2010 HUSM  
8.  Salmonella Enteritidis S00272/10 2010 HUSM  
9.  Salmonella Enteritidis S00275/10 2010 HUSM  
10. Salmonella Enteritidis S00294/10 2010 HUSM  
11. Salmonella Enteritidis S00457/10 2010 HUSM  
12.  Salmonella Enteritidis S00738/10 2010 HUSM  
13.  Salmonella Enteritidis S00754/10 2010 HUSM  
14. Salmonella Enteritidis S00755/10 2010 HUSM  
15.  Salmonella Enteritidis S00764/10 2010 HUSM  
16.  Salmonella Enteritidis S00780/10 2010 HUSM  
17. Salmonella Enteritidis S00923/10 2010 HUSM  
18.  Salmonella Enteritidis S01034/10 2010 HUSM  
19.  Salmonella Enteritidis U02775/10 2010 HUSM  
20. Salmonella Enteritidis B01779/11 2011 HUSM  
21. Salmonella Enteritidis B02184/11 2011 HUSM  
22. Salmonella Enteritidis B03102/11 2011 HUSM  
23. Salmonella Enteritidis S00054/11 2011 HUSM  
24. Salmonella Enteritidis S00059/11 2011 HUSM  
25. Salmonella Enteritidis S00081/11 2011 HUSM  
26. Salmonella Enteritidis S00186/11 2011 HUSM  
27. Salmonella Enteritidis S00230/11 2011 HUSM  
28. Salmonella Enteritidis S00270/11 2011 HUSM  
29. Salmonella Enteritidis S00450/11 2011 HUSM  
30. Salmonella Enteritidis S00556/11 2011 HUSM  
31. Salmonella Typhimurium S00481/10 2010 HUSM  
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33. Salmonella Typhimurium S00497/10 2010 HUSM  
34. Salmonella Typhimurium S00512/10 2010 HUSM  
35. Salmonella Typhimurium S00681/10 2010 HUSM  
36. Salmonella Typhimurium S00773/10 2010 HUSM  
37. Salmonella Typhimurium S00938/10 2010 HUSM  
38. Salmonella Typhimurium B03358/11 2011 HUSM  
39. Salmonella Typhimurium S00261/11 2011 HUSM  
40. Salmonella Typhimurium S00301/11 2011 HUSM  
41. Salmonella Typhimurium S00372/11 2011 HUSM  
42. Salmonella Typhimurium S00656/11 2011 HUSM  
43. Salmonella Weltevreden 2007-60-3289-1  2007 DTU 
44. Salmonella Weltevreden P01485/10 2010 HUSM  
45. Salmonella Weltevreden S00045/10 2010 HUSM  
46. Salmonella Weltevreden S00336/10 2010 HUSM  
47. Salmonella Weltevreden S00376/10 2010 HUSM  
48. Salmonella Weltevreden S00409/10 2010 HUSM  
49. Salmonella Weltevreden S00412/10 2010 HUSM  
50. Salmonella Weltevreden S00490/10 2010 HUSM  
51. Salmonella Weltevreden S00492/10 2010 HUSM  
52. Salmonella Weltevreden S00516/10 2010 HUSM  
53. Salmonella Weltevreden S00563/10 2010 HUSM  
54. Salmonella Weltevreden S00620/10 2010 HUSM  
55. Salmonella Weltevreden S00859/10 2010 HUSM  
56. Salmonella Weltevreden S00930/10 2010 HUSM  
57. Salmonella Weltevreden S00981/10 2010 HUSM  
58. Salmonella Weltevreden S00989/10 2010 HUSM  
59. Salmonella Weltevreden S00995/10 2010 HUSM  
60. Salmonella Weltevreden S00996/10 2010 HUSM  
61. Salmonella Weltevreden S01064/10 2010 HUSM  
62. Salmonella Weltevreden B01292/11 2011 HUSM  
63. Salmonella Weltevreden S00015/11 2011 HUSM  
64. Salmonella Weltevreden S00057/11 2011 HUSM  
65. Salmonella Weltevreden S00145/11 2011 HUSM  
66. Salmonella Weltevreden S00202/11 2011 HUSM  
67. Salmonella Weltevreden S00228/11 2011 HUSM  
68. Salmonella Weltevreden S00382/11 2011 HUSM  
69. Salmonella Weltevreden S00576/11 2011 HUSM  
70. Salmonella Weltevreden S00585/11 2011 HUSM  
71. Salmonella Weltevreden S00970/11 2011 HUSM  
72. Salmonella Weltevreden S00974/11 2011 HUSM  
73. Salmonella Weltevreden S00988/11 2011 HUSM  
74. Salmonella Weltevreden S01004/11 2011 HUSM  
75. Salmonella Agona MZ0008 - UCI 
76. Salmonella Agona MZ0693 - UCI 
77. Salmonella Agona MZ1431 - UCI 
78. Salmonella Agona MZ1608 - UCI 
79. Salmonella Agona MZ1609 - UCI 
80 Salmonella Agona MZ1610 - UCI 
81. Salmonella Agona 2009-60-2063 2009 DTU 
82. Salmonella Agona 2009-60-2107 2009 DTU 
83. Salmonella Agona 2010-60-0568 2010 DTU 
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85. Salmonella Agona 2011-60-0523 2011 DTU 
86. Salmonella Agona 2011-60-1289 2011 DTU 
87. Salmonella Agona 2011-60-1475 2011 DTU 
88. Salmonella Agona 2011-60-1697 2011 DTU 
89. Salmonella Agona 2011-60-3540 2011 DTU 
90. Salmonella Agona 2012-60-1061 2012 DTU 
91. Salmonella Agona 2012-60-1662 2012 DTU 
92. Salmonella Agona 2013-60-0214 2013 DTU 
93. Salmonella Agona 2013-60-1041 2013 DTU 
94. Salmonella Agona 2013-60-1082 2013 DTU 
95. Salmonella Agona 2013-60-1360 2013 DTU 
96. Salmonella Heidelberg B00050A/10 2010 HUSM  
97. Salmonella Heidelberg B00050B/10 2010 HUSM  
98. Salmonella Heidelberg S00491/10 2010 HUSM  
99. Salmonella Heidelberg S00840/10 2010 HUSM  
100. Salmonella Heidelberg S00992/10 2010 HUSM  
101. Salmonella Heidelberg 17705 - University of Liverpool 
102. Salmonella Heidelberg KMS1977 - University of Liverpool 
103. Salmonella Heidelberg 55/336 - University of Liverpool 
104. Salmonella Heidelberg 2005-60-0545 2005 DTU 
105. Salmonella Heidelberg 2006-60-1066 2006 DTU 
106. Salmonella Heidelberg 2006-60-1251 2006 DTU 
107. Salmonella Heidelberg 2006-60-1833 2006 DTU 
108. Salmonella Heidelberg 2007-60-2447 2007 DTU 
109. Salmonella Heidelberg 2008-60-0842 2008 DTU 
110. Salmonella Heidelberg 2010-60-0508 2010 DTU 
111. Salmonella Heidelberg 2010-60-6148 2010 DTU 
112. Salmonella Heidelberg 2011-60-0380 2011 DTU 
113. Salmonella Heidelberg 2011-60-1487 2011 DTU 
114. Salmonella Heidelberg 2012-60-1704 2012 DTU 
115. Salmonella Heidelberg 2012-60-2239 2012 DTU 





2.1.7 Target Specific Oligonucleotides 
The following target specific oligonucleotides were used to develop a single multiplex PCR 
assay (Table 2.8). Primers for S. Enteritidis and S. Typhimurium were obtained from my 
colleague, Ms. Yeoh Chiann Ying (Yeoh, 2014) with kind permission. Primers for S. 
Weltevreden, S. Agona and S. Heidelberg were designed in this study. An internal control 
(IC) primer pair targeting Pan-Salmonella, invasion gene (invA) which produces a 284 bp 
PCR product was used in this study. The primer sequences were adopted from Rahn et al. 
(1992). Based on their study, it has 95% sensitivity across Salmonella spp. An amplification 
control (AC) used in this study was the housekeeping gene of the bacteria kingdom, 16S 
rRNA gene. The primer sequences were designed by Marchesi et al. (1998) and were chosen 
in this study because they targeted the conserved region of the 16S rRNA gene sequence that 
has 97% sequence homology across all bacteria.  
 
Table 2.8: List of Oligonucleotides Used in mPCR Assay 
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2.1.8 Media Preparation for Bacteria Culturing Purposes 
2.1.8 (a) Nutrient Agar 
Nutrient agar was prepared by adding 28 g of nutrient agar powder to 1000 ml of distilled 
water by heating and stirring. The solution was autoclaved at 121oC for 15 minutes, and then 
the sterilized molten nutrient agar solution was placed in a water bath at 50oC. Twenty five 
millilitre aliquots of the molten nutrient agar solution were poured into sterile petri dishes 
and allowed to solidify at room temperature. The nutrient agar plates were stored at 4oC until 
ready for use. 
 
2.1.8 (b) Nutrient Broth 
Nutrient broth was prepared by adding 13 g of nutrient broth powder to 1000 ml of distilled 
water by heating and stirring. Ten millilitre aliquots of the solution were distributed into 
universal bottles and sterilized by autoclaving at 121oC for 15 minutes. The universal bottles 
were stored at 4oC until ready for use.  
 
2.1.8 (c) Xylose Lysine Deoxycholate (XLD) Agar 
Xylose Lysine Deoxycholate (XLD) agar was prepared by dissolving 53 g of XLD powder 
in 1000 ml of distilled water by heating and stirring. The solution was then placed in a water 
bath at 50oC. Twenty five millilitre aliquots of the molten XLD solution were poured into 
sterile petri dishes and allowed to solidify at room temperature. The agar plates were stored 
at 4oC until ready for use.  
 
2.1.8 (d) Triple Sugar Iron (TSI) Agar 
Triple sugar iron (TSI) agar was prepared by dissolving 65 g of TSI powder in 1000 ml of 
distilled water by heating and stirring. Four millilitre aliquots of the solution were pipetted 
into capped test tubes and sterilized by autoclaving at 121oC for 15 minutes. The molten TSI 
agar was allowed to solidify at room temperature with the test tubes inclined at 45o. The test 
tubes were stored at 4oC until ready for use. 
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2.1.8 (e) Simmons Citrate Agar 
Simmons citrate agar was prepared by dissolving 23 g of Simmons citrate agar powder in 
1000 ml of distilled water by heating and stirring. Two millilitre aliquots of the solution were 
pipetted into capped test tubes and sterilized by autoclaving at 121oC for 15 minutes. The 
molten agar was allowed to solidify at room temperature with the test tubes inclined at 45o. 
The test tubes were stored at 4oC until ready for use.  
 
2.1.8 (f) Urea Solution (40%) 
Urea solution (40% w/v) was prepared by dissolving 40 g of urea powder in 100 ml of 
autoclaved distilled water by stirring. The solution was stored at 4oC until ready for use. 
 
2.1.8 (g) Urea Base Agar  
Urea agar base was prepared by dissolving 2.4 g of urea agar base powder in 95 ml of 
distilled water by heating and stirring. The solution was placed in a water bath at 50oC and 5 
ml of 40% (w/v) urea solution [Section 2.1.8 (f)] was added and mixed well. One thousand 
and five hundreds microlitre aliquots were pipetted into capped test tubes and allowed to 
solidify at room temperature with the test tubes inclined at 45o. The test tubes were stored at 
4oC until ready for use.  
 
2.1.8 (h) Sulphate Indole Motility (SIM) Medium 
Sulphate indole motility (SIM) medium was prepared by dissolving 30 g of SIM powder in 
1000 ml of distilled water by heating and stirring. Two millilitre aliquots of the solution were 
pipetted into capped test tubes and sterilized by autoclaving at 121oC for 15 minutes. The 
solution was allowed to solidify at room temperature and stored at 4oC until ready for use. 
One drop of KOVACS reagent was added into each inoculated test tube after overnight 





2.1.8 (i) Methyl Red Vogas-Proskauer (MRVP) Medium 
Methyl red Vogas-Proskauer (MRVP) medium was prepared by dissolving 15 g of MRVP 
powder in 1000 ml of distilled water by heating and stirring. Two millilitre aliquots of the 
solution were pipetted into capped test tubes and sterilized by autoclaving at 121oC for 15 
minutes. The solution was allowed to solidify at room temperature and stored at 4oC until 
ready for use. One drop of methyl red solution was added into each inoculated test tube after 
overnight incubation and the changes were recorded immediately.  
 
2.1.8 (j) Selenite Cystine Broth 
Selenite cystine broth was prepared by dissolving 23 g of Selenite cystine broth powder in 
1000 ml of autoclaved distilled water by steaming for 7 minutes. The solution was allowed 
to cool at room temperature before storage at 4oC.  
 
2.1.8 (k) Sodium Chloride (NaCl) Solution 
Sodium chloride (NaCl) (0.9% w/v) was prepared by dissolving 9 g of NaCl in 1000 ml of 
distilled water. The solution was sterilized by autoclaving at 121oC for 15 minutes. The 
solution was stored at room temperature. 
 
2.1.8 (l) Polyvinylpyrrolidone (PVP) Solution 
Polyvinylpyrrolidone (PVP) solution (5% w/v) was prepared by dissolving 5 g of PVP in 
100 ml of distilled water by vigorous mixing. The solution was sterilized by autoclaving at 
121oC for 15 minutes. The solution was stored at 4oC until ready to use.   
 
  
